Skip to main navigation Skip to search Skip to main content

Heat-stable respiratory syncytial virus prefusion F protein oligomers and their use in immunological compositions

    • Mucosis BV

    Research output: PatentOther research output

    Abstract

    Heat-stable oligomeric recombinant polypeptides, presenting at least one antigenic epitope of the pre-fusion Respiratory Syncytial Virus (RSV) F protein, comprising the RSV F protein ectodomain, functionally deleted in the HRB region, transmembrane and cytoplasmic domains replaced with a heterologous trimerization domain, and absent two functional multibasic furin cleavage sites, are useful as antigenic components in immunogenic compositions useful in methods of inducing an immune response and vaccinate against RSV infections.
    Original languageEnglish
    Patent numberPCT/EP2014/054804
    IPCC07K 14/005 (2006.01)
    Priority date14/02/13
    Publication statusPublished - 12 Mar 2014

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Fingerprint

    Dive into the research topics of 'Heat-stable respiratory syncytial virus prefusion F protein oligomers and their use in immunological compositions'. Together they form a unique fingerprint.

    Cite this